A previous study found that tumor samples with high levels of CD8+ tumor-infiltrating lymphocytes were associated with good outcomes in bladder cancer and had significantly higher levels of genes encoding immune checkpoints, such as PD-L1 (Vidotto et al., 2019). This evidence concerns the gene CD8A and urinary bladder carcinoma.